HADAR FISHER, Ph.D.
Dr. Fisher earned her Ph.D. in Clinical Psychology from Bar-Ilan University. She did her first postdoc at the University of Haifa as part of the data science research center, a multi-disciplinary hub where she combined data science into the research of psychotherapy. Her goal is to improve treatment for depression by better recognizing the precise mechanisms that contribute to depression and exploring which interventions can target and address these underlying mechanisms. Specifically, she is interested in the role maladaptive and adaptive emotion dynamics in the development and treatment of depression. To explore this, she employs multi-modal assessment techniques, incorporating biological, behavioral markers, and automatic emotion recognition technologies. Dr. Fisher harnesses advanced statistical methods to effectively analyze extensive longitudinal mechanistic data. Presently, she is a recipient of the VATAT Scholarship Program for Outstanding Postdoctoral Students.
Martha J. Falkenstein, Ph.D.
Dr. Falkenstein is an instructor in psychology in the Department of Psychiatry at Harvard Medical School and the administrative director of the Office of Clinical Assessment and Research at the OCD Institute at McLean Hospital. She completed her doctoral training at American University under the mentorship of David Haaga, PhD. Dr. Falkenstein’s research focuses on mediators and moderators of treatment response in obsessive compulsive related and anxiety disorders. She has received funding from NIMH (K23 award), the International OCD Foundation and Harvard Medical School (Kaplen Fellowship and Livingston Award) for her work on cognitive and neural mechanisms of treatment response, as well as prediction and prevention of suicidality in individuals with these disorders.
Jennie Kuckertz, Ph.D.
Dr. Kuckertz graduated from the San Diego State University/UC San Diego Joint Doctoral Program in Clinical Psychology and completed her internship at McLean Hospital. Her research interests are in mechanisms of treatment for OCD, anxiety and affective disorders, including traditional interventions such as exposure and response prevention as well as novel cognitive bias modification programs. Dr. Kuckertz’s research uses advanced statistical methodology that appropriately leverages the full richness of longitudinal mechanistic data to examine impact on clinical outcomes. She is a current recipient of the Corneel Young Investigator Award. Her doctoral research on behavioral and neurobiological mechanisms of treatment response for children with OCD was funded through an NIMH F31.